P3.cr-20 the Effect of Pembrolizumab in EGFR Mutated Lung Adenocarcinoma Patients With PD-L1 Overexpression: Two Cases Report
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1999
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV